Cantor Fitzgerald Downgrades Ironwood Pharmaceuticals (IRWD) to Sell

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Cantor Fitzgerald Downgrades Ironwood Pharmaceuticals (IRWD) to Sell

Ironwood Pharma (IRWD) Tops Q3 EPS by 2c; Initiates Phase III Trial of 72 mcg Linaclotide

November 4, 2014 4:53 PM EST

Ironwood Pharma (NASDAQ: IRWD) reported Q3 EPS of ($0.30), $0.02 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $16.2 million versus the consensus estimate of $21.2 million.

The company also announced today the initiation of a Phase III clinical... More